Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BWK is a prominent long-term private equity firm based in Stuttgart, Germany, that specializes in providing growth and succession financing for medium-sized enterprises, with a deep historical focus on the life sciences and healthcare sectors. Founded in 1990 and backed by major institutional investors including L-Bank and the W&W Group, the firm is distinguished by its exceptionally long investment horizons, often holding and supporting companies for several decades. BWK is notably recognized in the pharmaceutical industry for its strategic, long-term ownership of market leaders such as LTS Lohmann Therapie-Systeme AG, the global leader in transdermal drug delivery, and R-Biopharm AG, a leader in clinical diagnostics and food analysis. The firm operates as a key financial architect for established German pharmaceutical suppliers, diagnostics companies, and medical technology manufacturers within the DACH region.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BWK.